2011
DOI: 10.3748/wjg.v17.i12.1519
|View full text |Cite
|
Sign up to set email alerts
|

Potential beneficial effects of butyrate in intestinal and extraintestinal diseases

Abstract: The multiple beneficial effects on human health of the short-chain fatty acid butyrate, synthesized from non-absorbed carbohydrate by colonic microbiota, are well documented. At the intestinal level, butyrate plays a regulatory role on the transepithelial fluid transport, ameliorates mucosal inflammation and oxidative status, reinforces the epithelial defense barrier, and modulates visceral sensitivity and intestinal motility. In addition, a growing number of studies have stressed the role of butyrate in the p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

17
681
0
27

Year Published

2011
2011
2024
2024

Publication Types

Select...
6
4

Relationship

1
9

Authors

Journals

citations
Cited by 1,027 publications
(731 citation statements)
references
References 100 publications
17
681
0
27
Order By: Relevance
“…Bifidobacteria, often stimulated by specific prebiotics, do not produce butyrate, so a probable scenario is that cross feeding by other bac teria must have resulted in production of this SCFA. Much has been reported about the benefits of butyrate in the gut and beyond 54 , leading to the potential of known butyrate producers such as Faecalibacterium prausnitzii, Eubacterium rectale or Roseburia spp. as possible pro biotics and, therefore, new prebiotic targets.…”
Section: Prebiotic Utilization and Host Healthmentioning
confidence: 99%
“…Bifidobacteria, often stimulated by specific prebiotics, do not produce butyrate, so a probable scenario is that cross feeding by other bac teria must have resulted in production of this SCFA. Much has been reported about the benefits of butyrate in the gut and beyond 54 , leading to the potential of known butyrate producers such as Faecalibacterium prausnitzii, Eubacterium rectale or Roseburia spp. as possible pro biotics and, therefore, new prebiotic targets.…”
Section: Prebiotic Utilization and Host Healthmentioning
confidence: 99%
“…Further, an increase in the villus height and villus height to crypt depth ratio are directly correlated with increased epithelial cell turnover (Fan et al, 1997) and an indicator of activated intestinal villi function (Langhout et al, 1999;Shamoto and Yamauchi, 2000) and it also stimulates intestinal blood flow. In addition, butyrate of stimulates cell growth and differentiation of normal cells and apoptosis (early cell death) of tumour cells which represents'butyrate paradox' (Canani et al, 2011).Previous studies showed increased jejunum villi height (Adil et al, 2010;Jerzsele et al, 2012;Chamba et al, 2014), villi height to crypt depth ratio (Hu and Guo, 2007;Shahir et al, 2013) and comparable crypt depth (Hu and Guo, 2007;Adil et al, 2010;Smulikowska et al, 2009;Chamba et al, 2014;Sayrafi et al, 2011;Antongiovanni et al, 2007) by supplementation of different forms of butyric acid. Lakshmi and Sunder (2015) 0.25 Liver weight + Aghazadeh and Yazdi (2012) It is clear from the Table 4 that inclusion of BA in broiler diet improves the weight of carcass indicating anabolic effect in broiler chicken.…”
Section: Antioxidant Effectmentioning
confidence: 99%
“…The SCFA butyrate, a main endproduct of microbial fermentation of dietary fibres in the human intestine, plays an important role in the maintenance of intestinal homeostasis and overall health status. The effects exerted by butyrate are multiple from the gut to the peripheral issues with a high potential for a therapeutic use in human medicine (57) . Butyrate is part of a class of epigenetic factors known as HDAC inhibitors, with several functions such as anti-inflammatory and anticarcinogenesis effects.…”
Section: Microbiota Epigenetics and Early Postnatal Nutritionmentioning
confidence: 99%